Advertisement
Singapore markets open in 34 minutes

  • Straits Times Index

    3,187.66
    +32.97 (+1.05%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • Dow

    37,775.38
    +22.07 (+0.06%)
     

  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     

  • Bitcoin USD

    63,041.70
    +1,966.71 (+3.22%)
     

  • CMC Crypto 200

    1,306.49
    +420.96 (+47.27%)
     

  • FTSE 100

    7,877.05
    +29.06 (+0.37%)
     

  • Gold

    2,390.40
    -7.60 (-0.32%)
     

  • Crude Oil

    82.60
    -0.13 (-0.16%)
     

  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     

  • Nikkei

    37,566.67
    -513.03 (-1.35%)
     

  • Hang Seng

    16,385.87
    +134.03 (+0.82%)
     

  • FTSE Bursa Malaysia

    1,544.76
    +4.34 (+0.28%)
     

  • Jakarta Composite Index

    7,166.81
    -7,130.84 (-49.87%)
     

  • PSE Index

    6,523.19
    +73.15 (+1.13%)
     

Top trending stocks after hours: Costco, Ford, Abbvie

Seana Smith
·Host
·1-min read

Costco (COST): Total comparable store sales rose 8.5% in September, beating Wall Street’s earnings estimate of 6.3% growth. Comparable sales excluding the impacts from changes in gasoline prices and foreign exchange rose 8.6%. Net sales for last month totaled $21.5 billion, up 10.1% from a year ago.

Ford (F): The company is raising the price of its F-150 lightning for the second time in recent months, driven by higher costs and supply chain issues. The 2023 F-150 Lightning Pro, which is aimed at commercial users, will cost $51,974, up $5,000 from its previous starting price. This is the second time Ford has raised the price for its F-150 Lightning in two months. In a statement, Ford said it is adjusting the price "due to ongoing supply chain constraints, rising material costs and other market factors" and that it plans to "continue to monitor pricing across the model year."

Abbvie (ABBV): The biopharmaceutical company said in a filing that its third-quarter earnings are expected to include acquired IPR&D and milestones expense of $40 million on a pre-tax basis. As a result, AbbVie’s third-quarter adjusted earnings per share guidance is $3.53 to $3.57 and its full-year 2022 adjusted EPS forecast is $13.76 to $13.96.

Click here for the latest trending stock tickers of the Yahoo Finance platform

ADVERTISEMENT

Click here for the latest stock market news and in-depth analysis, including events that move stocks

Read the latest financial and business news from Yahoo Finance

Download the Yahoo Finance app for Apple or Android

Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and YouTube